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Outpatient arthroplasty has gained popularity in recent years 
as the fast-track concept has evolved with optimized logistics 
and perioperative treatment leading to reduced length of stay in 
hospital (LOS) worldwide (Kehlet 2013, Berend et al. 2018a). 
The popularity of outpatient arthroplasty is further fueled by 
increased focus on value-based treatments and cost-effective-
ness, as outpatient procedures have been shown to have favor-
able financial benefits compared with in-hospital procedures 
(Lovald et al. 2014, Husted et al. 2018). Also, studies have 
shown that outpatient arthroplasty is feasible both for total hip 
arthroplasty (THA) and total knee arthroplasty (TKA), even in 
an unselected patient population (Goyal et al. 2016, Gromov 
et al. 2017). However, same-day discharge is reserved for a 
few selected patients and less then 1% of hip and knee arthro-
plasties in the United States are being performed as outpatient 
procedures (Basques et al. 2017, Courtney et al. 2017). While 
the majority of the studies have shown outpatient arthroplasty 
to be safe in a carefully selected patient population (Goyal et 
al. 2016, Courtney et al. 2017, Nelson et al. 2017), safety con-
cerns still remain regarding complications and readmissions 
(Lovecchio et al. 2016, Courtney et al. 2018). Therefore, more 
studies are needed to investigate early complications follow-
ing outpatient THA and TKA in a well-defined patient popula-
tion with complete follow-up. 
This prospective 2-center study investigated early readmis-
sions requiring at least one night in hospital and types of com-
plications following outpatient THA and TKA compared with 
a matched patient cohort treated within a standard fast-track 
setup requiring at least 1 night in hospital.
Background and purpose — Outpatient arthroplasty has 
gained popularity in recent years; however, safety concerns 
still remain regarding complications and readmissions. In a 
prospective 2-center study we investigated early readmis-
sions with overnight stay and complications following out-
patient total hip (THA) and total knee arthroplasty (TKA) 
compared with a matched patient cohort with at least 1 post-
operative night in hospital.
Patients and methods — All consecutive and 
unselected patients scheduled for THA or TKA at 2 partici-
pating hospitals were screened for potential day of surgery 
(DOS) discharge. Patients who fulfilled the DOS discharge 
criteria were discharged home. Patients discharged on DOS 
were matched on preoperative characteristics using propen-
sity scores to patients operated at the same 2 departments 
prior to the beginning of this study with at least 1 overnight 
stay. All readmissions within 90 days were identified.
Results — It was possible to match 116 of 138 outpa-
tients with 339 inpatient controls. Median LOS in the control 
cohort was 2 days (1–9). 7 (6%) outpatients and 13 (4%) inpa-
tient controls were readmitted within 90 days. Readmissions 
occurred between postoperative day 2–48 and day 4–58 in 
the outpatient and control cohorts, respectively. Importantly, 
we found no readmissions within the first 48 hours and no 
readmissions were related to the DOS discharge.
Interpretation — Readmission rates in patients dis-
charged on DOS may be similar to matched patients with at 
least 1 overnight stay. With the selection criteria used, there 
may be no safety signal associated with same-day discharge.
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Patients and methods
All consecutive and unselected patients referred to the 2 partic-
ipating departments and scheduled for unilateral THA or TKA 
were screened for participation in the study between Decem-
ber 2015 and September 2017. Outpatient surgery was defined 
as discharge to own home on day of surgery (DOS). Excluded 
were patients with ASA score > 2, patients with sleep apnea 
requiring treatment due to safety concerns if those patients 
were to be sent home with opioids, and patients operated as 
#3 in the operating room, as they were unlikely to be back on 
the ward in time to fulfill the functional discharge criteria on 
DOS. Finally, an adult had to be present at home for at least 
24 hours following discharge in order for the patients to par-
ticipate in outpatient surgery. Patients who fulfilled the DOS 
discharge criteria (Table 1, see Supplementary data) were dis-
charged home. Detailed patient eligibility and fulfillment of 
discharge criteria for a part of this cohort has previously been 
published (Gromov et al. 2017). The prospective outpatient 
cohort thus consisted of patients discharged on DOS from the 
2 departments during the study period. 
The in-patient control cohort consisted of propensity score 
matched TKA (n = 134) and THA (n = 205 patients operated 
at the same 2 departments from January 2013 to November 
2015 with at least 1 overnight stay—thus prior to introduc-
tion of outpatient THA and TKA surgery). All surgeries were 
performed in a standardized fast-track setup (Husted 2012) 
by surgeons specialized in THA and TKA surgery. The stan-
dard surgical protocol for both THA and TKA included spinal 
anesthesia, standardized fluid management, use of preopera-
tive intravenous tranexamic acid (TXA), preoperative single-
shot high-dose methylprednisolone, and absence of drains. 
Mechanical thromboprophylaxis and extended oral thrombo-
prophylaxis were not used. All THAs were performed using a 
standard posterolateral approach. All TKAs were performed 
with a standard medial parapatellar approach without the use 
of tourniquet with application of local infiltration analgesia 
(LIA). Rivaroxaban was used as oral thromboprophylaxis 
starting 6 to 8 hours postoperatively and continuing daily 
until discharge if LOS < 5 days. Patients discharged on DOS 
received oral thromboprophylaxis for 2 days. 
The patients were transferred from the postoperative recov-
ery unit to the ward after a few hours, where immediate mobi-
lization was attempted allowing full weight-bearing. Phys-
iotherapy was started on the day of surgery and continued 
until discharge. After the patients were back in the ward, the 
nurse and the physiotherapist screened them for fulfillment of 
discharge criteria (discharge criteria for DOS discharge con-
sisted of functional criteria that applied to all patients during 
the entire period as well as additional criteria for DOS dis-
charge (Table 1, See supplementary data). All patients were 
discharged to their own homes. The treatment of all patients 
from 2013 and throughout the study was standardized at both 
departments and was the same for all patients—both patients 
participating in outpatient surgery and those not participating. 
Both hospitals are reporting to the Lundbeck Foundation 
Centre for Fasttrack Hip and Knee Replacement Database 
(LCDB) (Jørgensen and Kehlet 2013b). All data on patient 
characteristics and comorbidities were thus prospectively 
recorded in the LCDB. 
Using the patients’ unique social security number (Central 
Office of Civil Registration), we obtained information on post-
operative LOS and 90-day readmissions and mortality from 
the Danish National Patient Registry (Andersen et al. 1999). 
As reporting to the Danish National Patient Registry is manda-
tory for hospitals to receive reimbursement, complete follow-
up is assured. All patients with LOS > 4 days had their medi-
cal records examined to determine the reason for prolonged 
LOS. All unplanned admissions with overnight stay following 
discharge within 90 days postoperatively were evaluated using 
discharge or patient records and included as readmissions if 
related to index surgery. Reasons and timing for readmission 
were recorded. 
Statistics
The propensity score (PS) was calculated using a logistic 
regression model. Covariates entered in the model were: age, 
sex, BMI, hospital, procedure, living situation, use of walk-
ing aids, smoking, alcohol use > 2 units/day (1 unit  = 12 g 
of alcohol), pharmacologically treated cardiovascular dis-
ease, pharmacologically treated pulmonary disease (PD), 
Type II diabetes (DM), use of anticoagulants, pharmacologi-
cally treated psychiatric disease, previous venous thrombo-
embolism (VTE), previous stroke, family history with VTE, 
and hypertension. As no patients in the outpatient cohort had 
Type 1 diabetes or preoperative anemia, patients with these 
2 comorbidities were excluded from the control cohort. A 
3:1 greedy nearest neighbor matching algorithm was used, 
excluding both cases and controls outside the area of common 
support. In 3 cases (3%), only 1 acceptable match was found 
and in 3 cases (3%) only 2 acceptable matches were found. 
For evaluation of successful matching we calculated the stan-
dardized differences.
Comparison of the outpatient and historical cohorts was done 
using the Mantel–Haenszel common odds ratio for weighted 
related data with a p-value of < 0.05 considered significant. 
Confidence intervals (CI) were all calculated as 95% CI.
Ethics, registration, funding, and potential conflict of 
interest 
Permission to store and review patient data without prior 
informed consent was obtained from the Danish Data protec-
tion Agency (RH-2017-132) and the Danish National Board 
of Health (3-3013-56/2/EMJO). LCBD is registered on Clini-
calTrials.gov (NCT01515670) as an ongoing study registry on 
preoperative patient characteristics and postoperative morbid-
ity. This study was supported by a research grant from Zimmer 
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Results
1,065 patients were screened for eligibility during the study 
period, 410 patients were eligible for outpatient surgery, and 
138 patients were discharged on DOS. 13 patients were not 
registered in the LCBD, 6 patients were missing 1 or several 
variables for matching, and 3 patients could not be matched, 
leaving 116 patients in the outpatient cohort for matching 
analysis (Figure). The control cohort consisted of 339 patients 
matched on the available comorbidities. Median LOS in the 
control cohort was 2 days (1–9). 4 patients in the control 
cohort had a LOS > 4 days (Table 3, see Supplementary data). 
7 (6%, CI 3–12) outpatients and 13 (4%, CI 2–6) inpatient 
controls were readmitted within 90 days (OR 1.6, CI 0.7–4), 
respectively (Tables 4 and 5, see Supplementary data). Suspi-
cion of deep venous thrombosis was the most common reason 
for readmission in both groups: 29% and 38% in the outpa-
tient and control cohort respectively. Readmissions occurred 
between postoperative day 2 and 48 and day 4 and 58 in the 
outpatient and control group respectively (Tables 4 and 5, see 
Supplementary data). Of the 22 patients discharged on DOS 
who were excluded from analysis, 1 was readmitted due to 
dislocation of the operated hip on postoperative day 72. 
Discussion
In this prospective 2-center cohort study with a matched con-
trol cohort, we found that 6% outpatients and 4% inpatient 
controls were readmitted within 90 days following THA and 
TKA. No patient was readmitted within 48 hours after surgery. 
Patients scheduled for unilateral THA or TKA
screened December 2015 – September 2017
n = 1,065 (THA/TKA = 575/490) 
Excluded from analysis (n = 22):
– not in the LCBD database, 13
– missing 1 or more variables, 6
– could not be matched, 3 
Eligibility criteria for
outpatient surgery not fulfilled
n = 655 (THA/TKA = 355/300) 
Discharged on day of surgery
n = 138 (THA/TKA = 80/58) 
Included in the matching analysis
n = 116 (THA/TKA = 70/46) 
Eligible for outpatient surgery
n = 410 (THA/TKA = 220/190) 
Patient inclusions and exclusions
Table 2. Preoperative characteristics of the total cohort of outpa-
tients and the matched cohorts of outpatients and non-outpatients. 
Frequency (%) unless otherwise specified
 PS-matched PS-matched
 outpatients non-outpatients  
Characteristic n = 116 n = 339 STD a
Age, mean (SD) 61 (11) 62 (10.4) 0.09
BMI, mean (SD) 28 (5) 28 (5) 0.01
Hospital     0.2
 A  76 (66) 219 (65) 
 B 40 (35) 120 (35) 
Procedure     0.0
 THA 70 (60) 205 (61) 
 TKA 46 (40) 134 (40) 
Sex     0.05
 Female 47 (41) 147 (43) 
 Male 69 (60) 192 (57) 
Social situation     0.02
 Living with others 102 (88) 300 (89) 
 Living alone 14 (12) 39 (12) 
Use of walking aid     0.0
 Yes 7 (6) 20 (94) 
 No 109 (94) 319 (6) 
Smoking     0.06
 Yes 23 (20) 78 (23) 
 No 93 (80) 261 (77) 
Alcohol > 2 units daily     0.02
 Yes 16 (14) 44 (13) 
 No 100 (87) 295 (87) 
Preoperative anemia     
 Yes 0  0  0.0
 No 116 (100) 339 (100) 
Pharmacologically treated psychiatric disorder    0.01
 Yes 8 (7) 22 (94) 
 No 108 (93) 317 (7) 
Pharmacologically treated pulmonary disease   0.05
 Yes 12 (10) 29 (9) 
 No 104 (90) 310 (91) 
Pharmacologically treated cardiac disease   0.01
 Yes 8 (7) 22 (7) 
 No 108 (93) 317 (93) 
Type-2 diabetes     0.06
 Yes 1 (1) 1 (0) 
 No 115 (99) 338 (100) 
Any anticoagulants      0.03
 Yes 6 (5) 21 (6) 
 No 110 (95) 318 (94) 
Previous venous thromboembolic event   0.03
 Yes 5 (4) 12 (4) 
 No 111 (96) 327 (97) 
Previous stroke     0.03
 Yes 9 (8) 30 (9) 
 No 107 (92) 309 (91) 
Family with venous thromboembolic event   0.03
 Yes 8 (7) 20 (6) 
 No 108 (93) 319 (94) 
Hypertension     0.03
 Yes 36 (31) 111 (33) 
 No 80 (69) 228 (67) 
a STD: standardized difference; a STD of > 0.1 was chosen as indica-
tive of imbalance.
PS: propensity score. SD: standard deviation. BMI: body mass index. 
THA: total hip arthroplasty TKA: total knee arthroplasty.  
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Previous studies with complete follow-up in a similar setup 
have reported 90 days readmission rates of between 9% and 
15% (Husted et al. 2010, Jørgensen and Kehlet 2013b). As 
patients in our study were selected for outpatient surgery and 
thus healthier compared with the average patient population, 
lower readmission rates are expected. Readmission rates 
found in our study are higher compared with some readmis-
sion rates previously published following outpatient THA and 
TKA from the United States, as a recent review by Hoffmann 
et al. (2018) reported only 2% 90-day readmission rates with 
similar low readmission rates reported by several other studies 
(Goyal et al. 2016, Basques et al. 2017, Berend et al. 2018b). 
Contrary to this, other studies from the United States have 
reported similar or even higher readmission rates following 
outpatient THA and TKA compared with our study: Springer 
et al. (2017) and Richards et al. (2018) reported 30-day read-
mission rates of 8%, while Berger et al. (2005) reported a 6% 
readmission rate within 90 days. The discrepancy in readmis-
sion rates following outpatient arthroplasty highlights varia-
tion in patient cohorts, definitions of readmission, follow-up 
method, and definitions of outpatient surgery (Saleh et al. 
2019). When comparing outcomes and safety aspects between 
studies describing outpatient surgery, it is important to be 
aware of the definition of outpatient surgery itself as some stud-
ies use < 24 hour stay as the definition, while others —like this 
study, define outpatient surgery as DOS discharge (Vehmeijer 
et al. 2018). It could be argued that we should have used all 
hospital contacts instead of only readmissions with overnight 
stay in hospital as a study outcome. However, while this is of 
economic and logistical interest when evaluating the potential 
benefits of DOS discharge, in our opinion increases in planned 
hospital visits or readmissions not requiring overnight stay in 
hospital are of less relevance when discussing potential safety 
issues. Our finding that suspicion of deep venous thrombosis, 
ruled out by ultrasound, was the main reason for readmission 
is in accordance with previous studies (Husted et al. 2010), 
and may explain the higher readmission rates in the current 
study compared with some other studies, as visits to the emer-
gency department with an overnight stay for diagnostics may 
not always be considered a readmission (Saleh et al. 2019), 
and may be diagnosed in the primary sector depending on the 
local logistical setup. Further on, as per department policy, 
we encourage all patients to contact the department in case 
of problems, which leads to potential readmissions that also 
would have been treated in the primary sector in a different 
setup. Finally, discharge location plays a role when comparing 
readmission. All patients in our study were discharged to their 
own home without any additional care, which might explain 
increased readmission rates compared with studies where 
patients are discharged to nursing care facilities or similar. 
Timing of readmission is of specific interest for outpatient 
arthroplasty. A main safety consideration following DOS dis-
charge is potential serious complications that are better treated 
during hospital admission, and potentially fatal if occurring at 
the patient’s own home such as thromboembolic events and 
pulmonary embolism, myocardial infection, and stroke (Jør-
gensen and Kehlet 2016, Petersen et al. 2018). This was high-
lighted by Parvizi et al. (2001), who warned against early dis-
charge from the hospital while pointing out that the majority 
of serious complications occurred in the early postoperative 
period within 4 days, while the patients are still in hospital. 
This has since been disputed, as studies have shown fast-track 
THA and TKA with a mean LOS of 1–2 days to be safe and 
with very low rates of thromboembolic events (Jørgensen and 
Kehlet 2013b, Petersen et al. 2018). A possible explanation for 
reduced complication rates in a fast-track setup is early mobi-
lization, which reduces the risk for TE events even with short 
TE prophylaxis during hospital stay only (Jørgensen et al. 
2013a). No complications in our study occurred within the first 
postoperative 48 hours, and the complications that did occur 
would most likely have resulted in readmissions even if the 
patients had a minimum of 1 overnight stay. We thus believe 
that the risk of serious complications in the early postoperative 
period is very low for patients with no or few systemic comor-
bidities that are deemed eligible for outpatient surgery. This is 
supported by Jørgensen and Kehlet. (2016), who showed that 
only 11% of all early (< 1 week) TE embolic events occurred 
in patients without pre-, peri-, or postoperative disposition, 
meaning that 89% of early TE events occurred in patients who 
would not be eligible for outpatient surgery. 
2 readmissions in the outpatient cohort were due to peri-
prosthetic fracture after a fall. It is possible to speculate 
that such a complication could potentially be avoided if the 
patients were kept in hospital longer for better mobilization 
and achievement of steady gait. However, fractures due to a 
fall occurred both during admission and after discharge in the 
control cohort, thus we do not believe that such complications 
can be prevented by a longer readmission, as they are related 
to patient characteristics rather that short LOS (Jørgensen and 
Kehlet 2013a).
2 readmissions in the outpatient cohort in our study were 
due to urinary retention on PO day 2 and 7. However, both 
patients had spontaneous urination prior to discharge (as 
required by discharge criteria); therefore those readmissions 
would most likely not be avoided even if the patients had a 
minimum of 1 overnight stay. Consequently, we believe that 
readmissions in the outpatient cohort were not related to the 
early DOS discharge. 
The low number of patients discharged on DOS is the main 
limitation of this study, thus making it difficult to draw defi-
nite conclusions on safety aspects for outpatient surgery. Our 
eligibility criteria were very broad, thus eligible patients who 
were not discharged on the DOS most likely differed from the 
patients who were discharged on DOS in a variety of param-
eters. To account for those potential differences we used the 
propensity score matching to match outpatients to a similar 
patient group (Table 2) from a retrospective cohort. As men-
tioned above, serious complications that are better handled 
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if occurring in hospital compared with patients’ own homes 
are the main safety concerns of outpatient surgery. How-
ever, such complications (pulmonary embolism, myocardial 
infection, and stroke) are extremely rare (< 0.1%) even in an 
unselected THA and TKA population (Jørgensen and Kehlet 
2016, Petersen et al. 2018), and presumably even more rare 
in a healthier selected population of patients deemed eligible 
for outpatient surgery (Jørgensen and Kehlet 2016). Thus, 
very large cohorts of patients discharged on DOS are required 
to make definite statements on safety aspects of outpatient 
surgery and an RCT on safety aspects of outpatient surgery 
would not be possible. Therefore we believe that continuous 
monitoring of complications following outpatient surgery in 
prospective cohort studies may be the optimal approach. 
In summary, we found comparable readmission rates in 
patients discharged on DOS and matched patients with at least 
1 overnight stay within a fast-track setup. Most importantly, 
we did not find any readmissions within the first 48 hours and 
found no readmissions to be related to the DOS discharge. 
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